These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10398811)

  • 1. The role of the amino acids associated with the HLA-Bw4/Bw6 epitope in peptide binding to HLA-B5, B35 CREG molecules.
    Sobao Y; Miwa K; Takiguchi M
    Immunogenetics; 1999 Aug; 49(9):819-22. PubMed ID: 10398811
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
    Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
    Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones.
    Matsumoto K; Yamamoto J; Hiraiwa M; Kano K; Takiguchi M
    Transplantation; 1990 Jun; 49(6):1164-7. PubMed ID: 2360256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.
    Sakaguchi T; Takamiya Y; Edidin M; Nokihara K; Miwa K; Schönbach C; Takiguchi M
    Immunogenetics; 1998; 47(2):149-58. PubMed ID: 9396861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.
    Ooba T; Hayashi H; Karaki S; Tanabe M; Kano K; Takiguchi M
    Immunogenetics; 1989; 30(2):76-80. PubMed ID: 2788131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
    Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
    Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
    Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
    J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes.
    Kosmoliaptsis V; Dafforn TR; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
    Hum Immunol; 2011 Nov; 72(11):1049-59. PubMed ID: 21840357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
    Yamamoto J; Kariyone A; Akiyama N; Kano K; Takiguchi M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2583-7. PubMed ID: 2157206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells.
    Nakayama S; Kawaguchi G; Karaki S; Nagao T; Uchida H; Kashiwase K; Akaza T; Nasuno T; Takiguchi M
    Hum Immunol; 1994 Mar; 39(3):211-9. PubMed ID: 8026989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group.
    Swelsen WT; Voorter CE; van den Berg-Loonen EM
    Tissue Antigens; 2002 Sep; 60(3):224-34. PubMed ID: 12445305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.
    Sekimata M; Hayashi H; Nakayama S; Kano K; Takiguchi M
    Immunogenetics; 1989; 30(3):229-31. PubMed ID: 2476390
    [No Abstract]   [Full Text] [Related]  

  • 14. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes.
    Hayashi H; Ooba T; Nakayama S; Sekimata M; Kano K; Takiguchi M
    Immunogenetics; 1990; 32(3):195-9. PubMed ID: 1699887
    [No Abstract]   [Full Text] [Related]  

  • 16. Conservation of genes encoding HLA-B5 and B35 cross-reactive group antigens in various races.
    Kato N; Ward F; Kano K; Takiguchi M
    Hum Immunol; 1992 Dec; 35(4):253-5. PubMed ID: 1293089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
    Lutz CT
    Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopes within the HLA-B5,B35 cross-reacting group.
    Ward FE; Stewart AD; Ruiz RE; Killian P; Amos DB; Johnson AH; Kostyu DD
    Hum Immunol; 1989 Nov; 26(3):151-67. PubMed ID: 2481660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults.
    Udhayakumar V; Ongecha JM; Shi YP; Aidoo M; Orago AS; Oloo AJ; Hawley WA; Nahlen BL; Hoffman SL; Weiss WR; Lal AA
    Eur J Immunol; 1997 Aug; 27(8):1952-7. PubMed ID: 9295031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.